|
Biliary cirrhosis
|
0.310 |
Biomarker
|
disease |
CTD_human |
Ectonucleotidase NTPDase2 is selectively down-regulated in biliary cirrhosis.
|
15651265 |
2004 |
|
Biliary cirrhosis
|
0.310 |
AlteredExpression
|
disease |
LHGDN |
Ectonucleotidase NTPDase2 is selectively down-regulated in biliary cirrhosis.
|
15651265 |
2004 |
|
Primary biliary cirrhosis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Ectonucleotidase NTPDase2 is selectively down-regulated in biliary cirrhosis.
|
15651265 |
2004 |
|
Secondary Biliary Cholangitis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Ectonucleotidase NTPDase2 is selectively down-regulated in biliary cirrhosis.
|
15651265 |
2004 |
|
Biliary Cirrhosis, Primary, 1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Ectonucleotidase NTPDase2 is selectively down-regulated in biliary cirrhosis.
|
15651265 |
2004 |
|
Hypertensive disease
|
0.200 |
Biomarker
|
group |
RGD |
L-NAME-treatment alters ectonucleotidase activities in kidney membranes of rats.
|
20655932 |
2010 |
|
Liver Cirrhosis, Experimental
|
0.200 |
Biomarker
|
disease |
RGD |
Ectonucleotidase NTPDase2 is selectively down-regulated in biliary cirrhosis.
|
15651265 |
2004 |
|
Endometriosis of uterus
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The aim of this study was to characterize the expression of NTPDase2 in human nonpathological cyclic and postmenopausic endometria and in adenomyosis.
|
31123897 |
2019 |
|
Neoplasm Metastasis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Extracellular ATP is mainly hydrolyzed by NTPDase1/CD39 and NTPDase2/CD39L1, generating AMP, which is hydrolyzed by ecto-5'-nucleotidase (CD73) to adenosine, a possible promoter of tumor growth and metastasis.
|
29455338 |
2018 |
|
Fibrosis, Liver
|
0.010 |
Biomarker
|
disease |
BEFREE |
After chronic CCl<sub>4</sub> intoxication, Entpd2 null mice exhibit significantly more severe liver fibrosis, as assessed by collagen content and histology.
|
29134411 |
2018 |
|
Liver regeneration disorder
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Liver regeneration after partial hepatectomy is not substantively impaired in global Entpd2 null mice.
|
29134411 |
2018 |
|
Malignant Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Our data suggest that ENTPD2 may be a good prognostic marker and therapeutic target for cancer patients, especially those receiving immune therapy.Myeloid-derived suppressor cells (MDSCs) promote tumor immune escape.
|
28894087 |
2017 |
|
Encephalomyelitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
The preservation of the proportion of GFAP single-labeled and GFAP/NTPDase2 double-labeled elements along the course of EAE indicated that changes in NTPDase2-<i>ir</i> occurred at fibrous astrocytes that typically express NTPDase2 in normal conditions.
|
29163045 |
2017 |
|
Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Our data suggest that ENTPD2 may be a good prognostic marker and therapeutic target for cancer patients, especially those receiving immune therapy.Myeloid-derived suppressor cells (MDSCs) promote tumor immune escape.
|
28894087 |
2017 |
|
Primary malignant neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
Our data suggest that ENTPD2 may be a good prognostic marker and therapeutic target for cancer patients, especially those receiving immune therapy.Myeloid-derived suppressor cells (MDSCs) promote tumor immune escape.
|
28894087 |
2017 |
|
Liver carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Overexpression of ENTPD2 is found as a poor prognostic indicator for HCC.
|
28894087 |
2017 |
|
Pancreatic carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Transcripts of ectonucleotidases (CD39 and CD39L1) together with P2R (P2X7, P2Y2, and P2Y6) are significantly increased in both chronic pancreatitis and pancreatic cancer.
|
16920697 |
2007 |
|
Malignant neoplasm of pancreas
|
0.010 |
Biomarker
|
disease |
BEFREE |
Transcripts of ectonucleotidases (CD39 and CD39L1) together with P2R (P2X7, P2Y2, and P2Y6) are significantly increased in both chronic pancreatitis and pancreatic cancer.
|
16920697 |
2007 |